A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Clinical trial NCT00420849 · COMPLETED

Trial details

NCT number: NCT00420849
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-11-01
Primary completion: 2009-10-01
Enrollment: 587

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.